|
Having trouble viewing this email? View it as a Web page.
| If you have trouble reading this e-mail, please click here. |
 |
|
Recommendations and Reports
Volume 62, No. RR-6
June 28, 2013 |
|
|
|
|
| Biosafety Recommendations for Work with Influenza Viruses Containing a Hemagglutinin from the A/goose/Guangdong/1/96 Lineage |
|
| |
|
| The recommendations in this report outline the essential baseline biosafety measures for working with the subset of influenza viruses that contain a hemagglutinin from the highly pathogenic avian influenza (HPAI) A/goose/Guangdong/1/96 lineage, including reassortant influenza viruses created in a laboratory setting. Work with HPAI H5N1 virus should be conducted, at a minimum, at biosafety level 3 (BSL-3), with specific enhancements to protect workers, the public, animal health, and animal products. Original clinical specimens suspected of containing viruses of this lineage can only be handled at BSL-2 if the procedures do not involve the propagation of the virus. An appropriate biosafety level should be determined in accordance with a biosafety risk assessment. |
|
 full text |
|
|
| |
Department of Health and Human Services
Centers for Disease Control and Prevention |
| This email was sent to list-cdc@xxxxxxxxxxx using GovDelivery, on behalf of: Centers for Disease Control and Prevention (CDC) · 1600 Clifton Rd · Atlanta, GA 30333 · 1-800-CDC-INFO (800-232-4636) |
 |
|
